Search Clinical Trials
115 matching studies
| Sponsor Condition of Interest |
|---|
|
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Carna Biosciences, Inc.
B-cell Malignancy
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Waldenstrom Macroglobulinemia
Mantle Cell Lymphoma
This is an open-label, multi-center Phase 1b clinical study of oral AS-1763
(docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or are intolerant
to ≥2 lines of systemic therapy. expand
This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or are intolerant to ≥2 lines of systemic therapy. Type: Interventional Start Date: Aug 2023 |
|
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patient1
Surgimab
Colorectal Neoplasms
The performance of SGM-101, an intraoperative imaging agent, will be compared to that of
standard "white light" visualization during surgical resections of colorectal cancer. expand
The performance of SGM-101, an intraoperative imaging agent, will be compared to that of standard "white light" visualization during surgical resections of colorectal cancer. Type: Interventional Start Date: Jun 2019 |